Linpeng Zheng

Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations

Linpeng Zheng, Yanmei Wang, Zihan Xu et al. · The Oncologist · 2019 · 79 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer

Qingzhu Jia, Lu-Ting Chiu, Shuangxiu Wu et al. · Advanced Science · 2020 · 78 citations · Full text

Medicine, Genetics, Oncology +17

Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients

Qiao Yang, Mingjing Chen, Jiaoyang Gu et al. · Frontiers in Immunology · 2021 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC

Jianmin Wang, Pu Zhou, Xudong Wang et al. · Cell Proliferation · 2019 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis

Qiao Yang, Zihan Xu, Xiewan Chen et al. · Thoracic Cancer · 2019 · 36 citations · Full text

Medicine, Oncology, Surgery +14